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40-07 Body Composition Analysis with Bioelectric 
Impedance Measurement in Neuromuscular Diseases 
K.-H. Krause, C.-D. Reimers, N. Goebels, R Berlit. Friedrich-Baur-lnstitut, 
University of Munich, RR. G. 
Most of generalized neuromuscular diseases show atrophy of muschs and 
mesenchymal alteration processes. Bioelectric impedance analysis (BA) is a 
fast and wel l tolerated procedure for measurement of body composi t im (fat, 
water) (Baumgartner, R. N. et al., J. Clin. Nutr. 48: 16,1988). 
BIA was assessed in 207 adult patients (110 males, 97 female:) w i t h 
neuromuscular diseases, conf irmed by clinical symptoms, electromyography, 
and muscle biopsy. The results were compared wi th those of 118 lealthy 
controls (65 males, 53 females). Using multiple regression and comlat ion 
analysis for sex, age, height, and weight normal values wi th s tndard 
deviations (SD) were established for the control group. The median v;lue of 
relative body fat [% of body weight ] in male patients lay 3.8 SD (p <0.001) 
(Mann-Whitney-U-test), in female patients 1.0 SD (p < 0.001) above hat of 
controls, the median value of relative body water [% of body weight ] ii male 
patients 2.5 SD (p < 0.001), and in females 1.1 SD (p < 0.001) below hat of 
the controls. 3 0 . 1 % of the male and 21 .4% of the female patients s iowed 
a minimal SD of 3.0 in percent body fat, compared wi th 7.7% of mahs and 
1.9% of females in the control group. The deviations were highly corelated 
wi th the severity of muscle weakness. 
In conclusion, BIA seems to be a very simple and fast, bit not 
very sensitive method for assessing the degree of muscle lipomatisis in 
generalized neuromuscular diseases. 
